692058-21-2

Basic information

• Product Name: tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate
• Synonyms: tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate;1-Boc-4-(2,2,2-trifluoroethyl)piperazine
• CAS NO: 692058-21-2
• Molecular Formula: C11H19F3N2O2
• Molecular Weight: 268.2759696
• Mol File: 692058-21-2.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate(692058-21-2)
• EPA Substance Registry System: tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate(692058-21-2)

Safety Data

• Hazardous Substances Data: 692058-21-2(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate is a chemical compound with the molecular formula C13H22F3N3O2. It is a piperazine derivative that contains a tert-butyl group and a trifluoroethyl group. tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate is often used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and therapeutic agents. It is also used in organic chemistry as a building block for the creation of more complex molecules. Tert-butyl 4-(2,2,2-trifluoroethyl)piperazine-1-carboxylate is a colorless to light yellow liquid and should be handled and stored with proper safety precautions.

Upstream product

• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 77278-37-6 4-(2,2,2-trifluoroacetyl)piperazine-1-carboxylic acid tert-butyl ester 
• 373-88-6 2,2,2-trifluroethylamine hydrochloride 
• 103898-12-0 N-(tert-butoxycarbonyl)iminodiacetaldehyde 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 
• 353-83-3 1,1,1-trifluoro-2-iodoethane 
• 75-89-8 2,2,2-trifluoroethanol 

Downstream Products

• 13349-91-2 1-(2,2,2-trifluoroethyl)piperazine hydrochloride 
• 13349-90-1 1-(2,2,2-trifluoroethyl)piperazine 

Relevant articles and documents

An Improved Stereocontrolled Access Route to Piperidine or Azepane β-Amino Esters and Azabicyclic β- and γ-Lactams; Synthesis of Novel Functionalized Azaheterocyles

An improved, efficient synthesis of some functionalized saturated azaheterocycles has been accomplished by controlled functionalization of various readily available cyclic compounds containing ring C=C bond. The stereocontrolled synthetic concept was based on the oxidative ring cleavage of various unsaturated scaffolds across ozonolysis followed by ring closing with double reductive amination with primary alkylamines or fluorinated alkylamines. The protocol provided versatile azaheterocyclic derivatives with a piperidine or azepane framework.

SUBSTITUTED PYRAZOLE COMPOUNDS AND METHODS OF USING THEM FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES

Disclosed are compounds useful, for example, in methods of treating hyperproliferative disorders such as cancer, methods of arresting the cell cycle in cancer cells, methods of inhibiting glutathione synthesis in cancer cells, and associated compounds for

BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION

The present invention relates to certain bis-heteroaryl compounds, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, Parkinson's disease with dementia, fronto- temporal dementia, Huntington's Disease, amyotrophic lateral sclerosis, and multiple system atrophy, and cancer including melanoma.